Unomr raises €166K Seed round
19 April 2025· Zurich, Switzerland· health, biotech, nanopore_technology, deep_tech, software_hardware, b2b
The new capital will be strategically deployed to boost research and development efforts, enabling UNOMR to refine its pioneering nanopore platform and extend its capabilities for high-throughput, accurate protein analysis. The funding will also be used to invest in acquiring state-of-the-art equipment, scaling up experimental processes to streamline data acquisition and analysis, and expanding the talented research team to foster collaborations with leading experts in the field.
Investors
LeadVenture Kick
About Unomr
Stage
Seed
Headquarters
Zurich, Switzerland
Founded
2022
Team Size
6–20
Sectors
healthbiotechnanopore_technologydeep_techsoftware_hardwareb2b